Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Duggan

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
JCO Precision Oncology|July 2, 2025
Polygenic Score Complements Family History and Lynch Syndrome Genes for Predicting Colorectal Cancer RiskTalia Y Helfand, Jun Wei, Ashley J Mulford, et al.
Nature Genetics|May 27, 2011
Principles for the post-GWAS functional characterization of cancer risk lociMatthew L Freedman, Alvaro N A Monteiro, Simon A Gayther, et al.
The Prostate|March 26, 2008
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African AmericansJielin Sun, Lina Purcell, Zhengrong Gao, et al.
Cancer Research|March 5, 2009
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancerWennuan Liu, Jishan Sun, Ge Li, et al.
Cancer Medicine|June 4, 2025
Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic ScoresBrendan Prassas, Zhuqing Shi, Huy Tran, et al.
Carcinogenesis|June 9, 2014
Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryAlexa J Resler, Karen W Makar, Laura Heath, et al.
Research and Practice in Thrombosis and Haemostasis|June 11, 2025
Development and validation of a genetic probability for venous thromboembolismZhuqing Shi, Ashley J Mulford, Huy Tran, et al.
International Journal of Molecular Epidemiology and Genetics|September 19, 2013
Phospholipase A2G1B polymorphisms and risk of colorectal neoplasiaClare Abbenhardt, Elizabeth M Poole, Richard J Kulmacz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342Eric P Winer, Donald A Berry, Susan Woolf, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
JCO Precision Oncology|July 2, 2025
Polygenic Score Complements Family History and Lynch Syndrome Genes for Predicting Colorectal Cancer RiskTalia Y Helfand, Jun Wei, Ashley J Mulford, et al.
Nature Genetics|May 27, 2011
Principles for the post-GWAS functional characterization of cancer risk lociMatthew L Freedman, Alvaro N A Monteiro, Simon A Gayther, et al.
The Prostate|March 26, 2008
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African AmericansJielin Sun, Lina Purcell, Zhengrong Gao, et al.
Cancer Research|March 5, 2009
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancerWennuan Liu, Jishan Sun, Ge Li, et al.
Cancer Medicine|June 4, 2025
Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic ScoresBrendan Prassas, Zhuqing Shi, Huy Tran, et al.
Carcinogenesis|June 9, 2014
Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryAlexa J Resler, Karen W Makar, Laura Heath, et al.
Research and Practice in Thrombosis and Haemostasis|June 11, 2025
Development and validation of a genetic probability for venous thromboembolismZhuqing Shi, Ashley J Mulford, Huy Tran, et al.
International Journal of Molecular Epidemiology and Genetics|September 19, 2013
Phospholipase A2G1B polymorphisms and risk of colorectal neoplasiaClare Abbenhardt, Elizabeth M Poole, Richard J Kulmacz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342Eric P Winer, Donald A Berry, Susan Woolf, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
Pageof 12